Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oseltamivir and Probenecid Dosing for Influenza Prophylaxis
NCT00304434Phase 4Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- Feb 2005
- Primary completion
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of oseltamivir in influenza, sponsored by United States Department of Veterans Affairs. Primary endpoint: Blood plasma concentrations equivalence at 15 days. Started Feb 2005; status: completed.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00304434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00304434.